Will rising supply and operational costs hamper GSK shares?

Despite recent acquisitions and a demerger, the GSK share price has suffered in the face of an ongoing legal battle. Still, analysts remain bullish on its long-term potential.

Why do FMCG's CFOs care about ROA and why should you?

Top trends in South Korean grocery in 2023

Global Supply Chains in a Post-Pandemic World

GlaxoSmithKline Company's Supply Chain Processes Essay Example [Free]

Ozempic Mania Tests Novo's Supply: EMEA Earnings Week Ahead - BNN

GSK focused on split as cost checks, COVID-19 easings aid earnings

AMP-activated protein kinase: A remarkable contributor to preserve

News updates from January 25: US economy grows 3.3% in fourth

Live news updates from February 1: Fed lifts rates 0.25 points

GSK delivers strong Q1 2022 sales of £9.8 billion, +32% AER, +32

GSK share price rises 2% on buoyant vaccine sales

HowToRaiseRequest - GrantsAndDonations

Unhealthy competition hampers chemical firms' business recovery